Minerva Neurosciences (NERV) Tops Q3 EPS by 398c

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of $2.97, $3.98 better than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Microsoft Has Considered Xbox Unit Spinout - Information
• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO